Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;22(2):43-51.
doi: 10.1016/j.bjae.2021.10.002. Epub 2021 Dec 21.

Management of patients with suspected placenta accreta spectrum

S C Reale  1 , M K Farber  1
Affiliations
Review

Management of patients with suspected placenta accreta spectrum

S C Reale et al. BJA Educ. 2022 Feb.
No abstract available

Keywords: Caesarean section; hysterectomy; obstetric anaesthesia; placenta accreta; post-partum haemorrhage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig 1
Fig 1
Ultrasonographic evidence and specimen confirmation of placenta increta. (A) Ultrasonography at 30 weeks, 6 days demonstrating placenta praevia, placental lakes (star), increased vascularity at the bladder–myometrial border (arrow) and loss of distinction between the placental–myometrial border anteriorly and the myometrial–bladder border laterally. (B) Uterus and placenta post-Caesarean delivery/hysterectomy, with a densely adherent placenta and large circumferential placental bulge. The fundus has a classical hysterotomy closure (arrow). The hypervascularised placenta can be visualised in the low uterine segment, overlying the cervical os (star). Used with written consent from the patient.
Fig 2
Fig 2
Algorithm for patients with suspected placenta accreta spectrum. FFP, fresh frozen plasma; PRBC, packed red blood cells; ROTEM, rotational thromboelastometry; TEG, thromboelastography; TOE, transoesophageal echocardiography; TTE, transthoracic echocardiography. Adapted with permission from King and colleagues.
See this image and copyright information in PMC

References

    1. Bailit J.L., Grobman W.A., Rice M.M., et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125:683–689. - PMC - PubMed
    1. Silver R.M., Landon M.B., Rouse D.J., et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226–1232. - PubMed
    1. Obstetric care consensus no. 7 summary: placenta accreta spectrum. Obstet Gynecol. 2018;132:1519–1521. - PubMed
    1. Silver R.M., Branch D.W. Placenta accreta spectrum. N Engl J Med. 2018;378:1529–1536. - PubMed
    1. Shamshirsaz A.A., Fox K.A., Salmanian B., et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212:218. e1–9. - PubMed